Benjamin G. Keselowsky;Judit Cserny;Todd M. Brusko
发明人:
Todd M. Brusko,Benjamin G. Keselowsky,Judit Cserny
申请号：
US14241228
公开号：
US09913830B2
申请日:
2012.09.10
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention provides nanoparticle-coupled tolerogenic Treg cell therapy for treatment of immune and/or autoimmune disorders. In certain specific embodiments, the present invention can be used in the prevention and/or treatment of autoimmune diseases including, but not limited to, type 1 diabetes, lupus erythematosus (SLE), multiple sclerosis (MS), inflammatory bowel disease (IBD), rheumatoid arthritis, oophoritis, and autoimmune pathology associated with Graft versus Host Disease (GvHD) following hematopoietic stem cell transplantation.
